55816 Federal Register / Vol. 62, No. 208 / Tuesday, October 28, 1997 / Notices

health effect or outcome, identifying

individuals in need of further diagnosis or

treatment, and arranging for appropriate

referrals.

Section 104(i)(9) of the Comprehensive

Environmental Response, Compensation, and

Liability Act (CERCLA), as amended (42

U.S.C. 9604(i)(9)), provides for the

Administrator, ATSDR to initiate a health

surveillance program for populations at

significantly increased risk of adverse health

effects as a result of exposure to hazardous

substances released from a facility. A

program included under health surveillance

is referred to as ‘‘medical monitoring or

screening’’ by ATSDR and is defined in the

legislation as ‘‘the periodic medical testing to

screen people at significant increased risk for

disease.’’

ATSDR has established criteria to

determine when medical monitoring is an

appropriate health activity and the

requirements for establishing a medical

monitoring program at a site. The legislation

also states that a mechanism to refer people

for treatment should be included in the

program. This statutory provision does not

authorize ATSDR to provide medical

treatment. Medical monitoring is a

community service, not a health study.

ATSDR is convening three expert

workshops to assist in the evaluation of a

medical monitoring program at the Bunker

Hill site. If a program is deemed appropriate,

the agency will develop a medical

monitoring plan for the target population(s).

The first workshop, considering the first four

ATSDR medical monitoring criteria, took

place on August 19–20, 1997. The second

workshop, which took place on September

23–24, 1997, examined more closely the

health outcomes recommended by the first

workshop and considered screening tests and

protocols appropriate to a medical

monitoring program. This document gives

notice of the third workshop.

Matters to be Considered: The third

workshop will reconvene the first

workshop’s participants and other experts as

needed to:

• Consider the application of the final

three medical monitoring criteria as

developed by ATSDR, and review ATSDR’s

application of these criteria, to the Bunker

Hill site

• Provide individual recommendations

and guidance on issues of science and public

health practice related to program

implementation

• Provide individual expertise and

guidance in conducting a medical outcome

and decision analysis to evaluate the public

health benefits and risks of a medical

monitoring program related to the Bunker

Hill site.

The experts will use information from the

first and second workshops and other

relevant data to make individual

recommendations and answer questions

related to key issues including the logistics,

program infrastructure, benefit analysis, and

other aspects of the medical monitoring

system criteria for each candidate health

outcome.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information:

Vivian Rush, M.D., Medical Officer, ATSDR,

Division of Health Education and Promotion,

1600 Clifton Road, NE, M/S E–33, Atlanta,

Georgia 30333, telephone 404/639–5080, or

Gregory Thomas, Senior Regional

Representative, ATSDR Region X, telephone

206/553–2113.

Dated: October 22, 1997.

Julia M. Fuller,

Acting Director, Management Analysis and

Services Office Centers for Disease Control

and Prevention (CDC).

[FR Doc. 97–28483 Filed 10–27–97; 8:45 am]

BILLING CODE 4163–70–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Toxic Substances and

Disease Registry

[ATSDR–128]

Availability of Draft Toxicological

Profiles

AGENCY: Agency for Toxic Substances

and Disease Registry (ATSDR),

Department of Health and Human

Services (HHS).

ACTION: Notice of availability.

SUMMARY: The Comprehensive

Environmental Response,

Compensation, and Liability Act of 1980

(CERCLA), as amended by the

Superfund Amendments and

Reauthorization Act of 1986 (SARA) (42

U.S.C. 9604(i)(3)) directs the

Administrator of ATSDR to prepare

toxicological profiles of priority

hazardous substances and to revise and

publish each updated toxicological

profile as necessary. This notice

announces the availability of ten

updated drafts and three new draft

toxicological profiles, comprising the

11th set, prepared by ATSDR for review

and comment.

DATES: To ensure consideration,

comments on these draft toxicological

profiles must be received on or before

February 17, 1998. Comments received

after the close of the public comment

period will be considered at the

discretion of ATSDR based upon what

is deemed to be in the best interest of

the general public.

ADDRESSES: Requests for copies of the

draft toxicological profiles or comments

regarding the draft toxicological profiles

should be sent to the attention of Ms.

Loretta Norman, Division of Toxicology,

Agency for Toxic Substances and

Disease Registry, Mailstop E–29, 1600

Clifton Road, NE., Atlanta, Georgia

30333.

Requests for the draft toxicological

profiles must be in writing, and must

specifically identify the hazardous

substance(s) profile(s) that you wish to

receive. ATSDR reserves the right to

provide only one copy of each profile

requested, free of charge. In case of

extended distribution delays, requestors

will be notified.

Written comments and other data

submitted in response to this notice and

the draft toxicological profiles should

bear the docket control number ATSDR–

128. Send one copy of all comments and

three copies of all supporting

documents to the Division of Toxicology

at the above address by the end of the

comment period. Because all public

comments regarding ATSDR

toxicological profiles are available for

public inspection after the profile is

published in final, no confidential

business information should be

submitted in response to this notice.

FOR FURTHER INFORMATION CONTACT: Ms.

Loretta Norman, Division of Toxicology,

Agency for Toxic Substances and

Disease Registry, Mailstop E–29, 1600

Clifton Road, NE., Atlanta, Georgia

30333, telephone (404) 639–6322.

SUPPLEMENTARY INFORMATION: The

Superfund Amendments and

Reauthorization Act (SARA) (Pub. L.

99–499) amends the Comprehensive

Environmental Response,

Compensation, and Liability Act

(CERCLA or Superfund) (42 U.S.C. 9601

et seq.) by establishing certain

responsibilities for the ATSDR and the

Environmental Protection Agency (EPA)

with regard to hazardous substances

which are most commonly found at

facilities on the CERCLA National

Priorities List (NPL). Among these

statutory provisions is that the

Administrator of ATSDR prepare

toxicological profiles for substances

included on the priority lists of

hazardous substances. These lists

identified 275 hazardous substances

that ATSDR and EPA determined pose

the most significant potential threat to

human health. The availability of the

revised priority list of 275 hazardous

substances was announced in the

Federal Register on April 29, 1996 (61

FR 18744 ). For prior versions of the list

of substances see Federal Register

notices dated April 17, 1987 (52 FR

12866); October 20, 1988 (53 FR 41280);

October 26, 1989 (54 FR 43619); October

17, 1990 (55 FR 42067); October 17,

1991 (56 FR 52166); October 28, 1992

(57 FR 48801); and February 28, 1994

(59 FR 9486). CERCLA also requires

ATSDR to assure the initiation of a

research program to fill data needs

associated with the substances.

Section 104(i)(3) of CERCLA (42

U.S.C. 9604(i)(3)) outlines the content of
Federal Register / Vol. 62, No. 208 / Tuesday, October 28, 1997 / Notices 55817

these profiles. Each profile will include

an examination, summary and

interpretation of available toxicological

information and epidemiologic

evaluations. This information and these

data are to be used to ascertain the

levels of significant human exposure for

the substance and the associated health

effects. The profiles must also include a

determination of whether adequate

information on the health effects of each

substance is available or in the process

of development. When adequate

information is not available, ATSDR, in

cooperation with the National

Toxicology Program (NTP), is required

to assure the initiation of research to

determine these health effects.

Although key studies for each of the

substances were considered during the

profile development process, this

Federal Register notice seeks to solicit

any additional studies, particularly

unpublished data and ongoing studies,

which will be evaluated for possible

addition to the profiles now or in the

future.

The following draft toxicological

profiles will be made available to the

public on or about October 17, 1997.

DocumentHazardous

substance CAS No.

1. .......... ALUMINUM .......... 007429–90–5

ALUMINUM

CHLORIDE.

007446–70–0

ALUMINUM

CHLOROHYDRATE.

001327–41–9

.......................... 11097–68–0

.......................... 4861–98–3

ALUMINUM LACTATE.18917–91–4

ALUMINUM HYDROXIDE.021645–51–2

ALUMINUM

OXIDE.

001344–28–1

ALUMINUM NITRATE.13473–90–0

ALUMINUM

PHOSPHATE.

007784–30–7

ALUMINUM

PHOSPHIDE.

020859–73–8

ALUMINUM FLUORIDE.007784–18–1

ALUMINUM SULFATE.010043–01–3

2. .......... CHLOROETHANE 000075–00–3

3. .......... CHLOROMETHANE.000074–87–3

4. .......... 1,2-

DICHLOROBENZENE.

000095–50–1

1,3-

DICHLOROBENZENE.

000541–73–1

1,4-

DICHLOROBENZENE.

000106–46–7

CHLOROBENZENE.000108–90–7

DocumentHazardous

substance CAS No.

DICHLOROBENZENE 025321–

22–6.

5. .......... 3,3,-

DICHLOROBENZIDINE.

00091–94–1

6. .......... 2,4-DINITROTOLUENE.000121–14–2

2,6-DINITROTOLUENE.000606–20–2

7. .......... ETHYL BENZENE 000100–41–4

8. .......... HEXANE ............... 000110–54–3

9. .......... LEAD .................... 007439–02–1

10. ........ MERCURY ........... 007439–97–6

MERCURIC (II)

ACETATE.

001600–27–7

MERCURIC (II)

SULFIDE.

001134–48–5

MERCURIC (I)

CHLORIDE.

010112–91–1

METHYLMERCURIC CHLORIDE.000115–09–3

PHENYLMERCURIC ACETATE.000062–38–4

11. ........ PHENOL ............... 000108–95–2

12. ........ SULFURIC ACID .. 007664–93–9

SULFUR TRIOXIDE.007446–11–9

13. ........ SULFUR DIOXIDE 007446–09–5

In regards to the draft Toxicological

Profile for Mercury, it should be noted

that the EPA is currently in the process

of developing a comprehensive

assessment of the potential adverse

effects of mercury emissions on human

health and wildlife. In addition, ATSDR

is also aware of a number of other

ongoing studies which are investigating

the potential for human health effects

from mercury exposure. Because of

these special circumstances, ATSDR

will monitor these efforts very closely

during the public comment period; any

meaningful and compelling information

from these efforts will be critically

evaluated for incorporation into the

final Toxicological Profile for Mercury,

as appropriate.

All profiles issued as ‘‘Drafts for

Public Comment’’ represent ATSDR’s

best efforts to provide important

toxicological information on priority

hazardous substances. We are seeking

public comments and additional

information which may be used to

supplement these profiles. ATSDR

remains committed to providing a

public comment period for these

documents as a means to best serve

public health and our clients.

Dated: October 22, 1997.

Georgi Jones,

Director, Office of Policy and External Affairs,

Agency for Toxic Substances and Disease

Registry.

[FR Doc. 97–28474 Filed 10–27–97; 8:45 am]

BILLING CODE 4163–70–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Toxic Substances and

Disease Registry

[ATSDR–129]

Availability of Draft Toxicological

Profiles

AGENCY: Agency for Toxic Substances

and Disease Registry (ATSDR),

Department of Health and Human

Services (HHS).

ACTION: Notice of availability.

SUMMARY: This notice announces the

availability of two new draft

toxicological profiles, comprising the

1st set developed for the Department of

Energy, prepared by ATSDR for review

and comment.

DATES: To ensure consideration,

comments on these draft toxicological

profiles must be received on or before

February 17, 1998. Comments received

after the close of the public comment

period will be considered at the

discretion of ATSDR based upon what

is deemed to be in the best interest of

the general public.

ADDRESSES: Requests for copies of the

draft toxicological profiles or comments

regarding the draft toxicological profiles

should be sent to the attention of Ms.

Loretta Norman, Division of Toxicology,

Agency for Toxic Substances and

Disease Registry, Mailstop E–29, 1600

Clifton Road, NE., Atlanta, Georgia

30333.

Requests for the draft toxicological

profiles must be in writing, and must

specifically identify the hazardous

substance(s) profile(s) that you wish to

receive. ATSDR reserves the right to

provide only one copy of each profile

requested, free of charge. In case of

extended distribution delays, requestors

will be notified.

Written comments and other data

submitted in response to this notice and

the draft toxicological profiles should

bear the docket control number ATSDR–

129. Send one copy of all comments and

three copies of all supporting

documents to the Division of Toxicology

at the above address by the end of the

comment period. Because all public

comments regarding ATSDR

toxicological profiles are available for

public inspection after the profile is

published in final, no confidential

business information should be

submitted in response to this notice.

FOR FURTHER INFORMATION CONTACT: Ms.

Loretta Norman, Division of Toxicology,

Agency for Toxic Substances and

Disease Registry, Mailstop E–29, 1600